What If Vaginal Leukoplakia Pathology Is Inconclusive?
At a Glance
An inconclusive vaginal leukoplakia biopsy or mismatch with colposcopy does not automatically mean cancer. It means more information may be needed, such as specialist slide review, deeper tissue levels, a repeat targeted biopsy, a larger sample, or close monitoring.
In this answer
4 sections
If your pathology report is unclear or disagrees with what your doctor saw during colposcopy, it simply means more information is needed to make an accurate diagnosis. Vaginal leukoplakia is a clinical term for a white patch on the vaginal lining; it is not a specific disease, and can be caused by benign inflammation, scarring, or precancerous changes [1]. An inconclusive biopsy does not automatically mean you have cancer. However, because small vaginal biopsies can sometimes miss the most severe part of a lesion, your doctor will carefully investigate further to ensure an accurate diagnosis and a safe follow-up plan [2].
Why Biopsies and Visual Findings Sometimes Disagree
Doctors call it clinical-pathologic discordance when the visual severity of a lesion during a colposcopy (the clinical exam) does not match the results under the microscope (the pathology). This can happen for several reasons:
- Sampling limitations: A standard punch biopsy takes a very small piece of tissue. It is possible to sample a milder area of a white patch while missing a nearby high-grade precancer, formally called a high-grade vaginal squamous intraepithelial lesion (vaginal HSIL; older reports may call this VaIN 2 or VaIN 3) [2]. Studies show that colposcopy-directed biopsies can sometimes underdiagnose high-grade vaginal lesions [3].
- Specimen quality: The tissue sample might be crushed during the biopsy, affected by cautery (heat), or cut at an angle that makes it difficult for the pathologist to read clearly.
- Hidden lesions and history: If you have had a prior hysterectomy—especially if it was performed for HPV-related cervical disease—vaginal lesions can hide in the surgical scar at the top of the vagina (the vaginal vault), making them harder to fully visualize and biopsy [4].
- Visual limitations: The naked eye cannot see cells. A white patch might look concerning but actually be benign inflammation, or conversely, a mildly abnormal-looking area might contain high-grade cells [5]. This is why abnormal cytology (Pap smear) or HPV results require thoughtful follow-up, even if a single small biopsy comes back negative [6].
Next Steps in the Pathology Lab
Before doing another physical procedure, your doctor can ask the laboratory to extract more information from the tissue sample they already have.
- Gynecologic pathologist review: Not all pathologists specialize in the female reproductive tract. Having an expert gynecologic pathologist review your slides can help clarify an ambiguous report.
- Deeper tissue levels: The pathologist can slice further into the original wax tissue block to see if deeper layers reveal a clearer picture.
- Immunostains (p16 and Ki-67): The lab may apply special chemical markers to the tissue. The p16 stain highlights proteins linked to HPV activity, and Ki-67 highlights rapid cell growth [7]. These stains do not diagnose cancer or high-grade precancer on their own. Instead, they act as supporting tools that help the pathologist interpret borderline cell changes [8]. The pathologist will decide if these stains are medically useful for your specific tissue sample.
Next Steps in the Clinic
If the laboratory cannot resolve the uncertainty, your doctor will need to evaluate the area again. Timely follow-up is important, and you may be referred to a specialist, such as a gynecologic oncologist.
- Repeat directed biopsy: Your doctor may perform another colposcopy to take new, carefully targeted biopsies from different areas [6].
- Diagnostic Excisional Procedure: If there is a strong suspicion of a high-grade lesion, or if the pathology report uses wording like “cannot exclude invasion,” your doctor may discuss a surgical excision [9] [10]. Excision is one option used to remove a larger, deeper piece of tissue to get a definitive answer [11]. However, excision is not an automatic requirement for every patient; the decision depends on the lesion’s size, your medical history, and whether the specialist feels it is necessary. Like all surgeries, excision has trade-offs and risks, including bleeding, scarring, vaginal narrowing, and potential discomfort with sex.
- Monitoring: If the specialist determines the lesion is low-grade and invasion has been safely ruled out, they may recommend close monitoring with regular cytology and HPV testing [9].
Understanding Unclear Pathology Wording
Pathology reports can be frightening to read. If you see phrases like “inability to exclude invasion” or “suspicious for, but not diagnostic of,” this does not mean the pathologist found invasive cancer. It often means the sample was too small, superficial, or fragmented to clearly see the basement membrane—the vital boundary separating the surface layer of vaginal mucosa from the deeper connective tissue (stroma).
Without clearly seeing this boundary, the pathologist cannot definitively determine if abnormal cells have crossed it. The standard medical response to this uncertainty is to obtain a better tissue sample or have a specialist review the case, not to panic [9] [12].
Note: While an inconclusive biopsy is rarely an emergency, you should contact your medical team promptly if you develop new symptoms such as heavy vaginal bleeding, severe pelvic pain, a growing mass, or foul-smelling discharge.
Common questions in this guide
Does an inconclusive vaginal leukoplakia biopsy mean I have cancer?
What can cause a biopsy result to differ from what was seen during colposcopy?
Can my existing vaginal biopsy be reviewed before I have another procedure?
What follow-up is used when vaginal leukoplakia pathology remains uncertain?
What does “cannot exclude invasion” mean on a vaginal pathology report?
When should I contact my medical team promptly?
Related questions
Show more
Get notified when new evidence is published on leukoplakia of vagina.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Vulvar Lichen Sclerosus et Atrophicus.
Nair PA
Journal of mid-life health 2017; (8(2)):55-62 doi:10.4103/jmh.JMH_13_17.
PMID: 28706405 - 2
Vaginal Intraepithelial Neoplasia: Histopathological Upgrading of Lesions and Evidence of Occult Vaginal Cancer.
Sopracordevole F, De Piero G, Clemente N, et al.
Journal of lower genital tract disease 2016; (20(1)):70-4 doi:10.1097/LGT.0000000000000150.
PMID: 26461231 - 3
Accuracy of colposcopic findings in detecting vaginal intraepithelial neoplasia: a retrospective study.
Stuebs FA, Koch MC, Mehlhorn G, et al.
Archives of gynecology and obstetrics 2020; (301(3)):769-777 doi:10.1007/s00404-020-05441-5.
PMID: 31993733 - 4
Research progress on HPV-related vaginal wall lesions after hysterectomy.
Zhang D, Xu B
Frontiers in oncology 2026; (16()):1897256 doi:10.3389/fonc.2026.1897256.
PMID: 42694624 - 5
Correlation Between Colposcopic Patterns and Histological Grade of Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study.
Monti E, Matozzo CMM, Cetera GE, et al.
Anticancer research 2023; (43(10)):4637-4642 doi:10.21873/anticanres.16658.
PMID: 37772563 - 6
[Consistency of diagnosis between cervical cytology and colposcopic biopsy diagnosis].
Zhang H, Xiao JN, Tao X, et al.
Zhonghua bing li xue za zhi = Chinese journal of pathology 2018; (47(6)):444-448 doi:10.3760/cma.j.issn.0529-5807.2018.06.011.
PMID: 29886589 - 7
Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
Clark JL, Lu D, Kalir T, Liu Y
Human pathology 2016; (55()):51-6.
PMID: 27134110 - 8
p16 Immunohistochemistry Is Not Always Required For Accurate Diagnosis of Grade 2 Squamous Intraepithelial Lesions.
Sun L, Zhang L, Krigman HR, Hagemann IS
Journal of lower genital tract disease 2018; (22(2)):104-109 doi:10.1097/LGT.0000000000000370.
PMID: 29570565 - 9
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
Kesic V, Carcopino X, Preti M, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(4)):446-461 doi:10.1136/ijgc-2022-004213.
PMID: 36958755 - 10
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial Neoplasia.
Kesic V, Carcopino X, Preti M, et al.
Journal of lower genital tract disease 2023; (27(2)):131-145 doi:10.1097/LGT.0000000000000732.
PMID: 36951985 - 11
Management options for vaginal intraepithelial neoplasia.
Rountis A, Pergialiotis V, Tsetsa P, et al.
International journal of clinical practice 2020; (74(11)):e13598 doi:10.1111/ijcp.13598.
PMID: 32602195 - 12
Clinical Characteristics and Long-Term Follow-up of Patients Treated for High-Grade Vaginal Intraepithelial Neoplasia: Results From a 20-Year Survey in Italy.
Sopracordevole F, Clemente N, Di Giuseppe J, et al.
Journal of lower genital tract disease 2020; (24(4)):381-386 doi:10.1097/LGT.0000000000000567.
PMID: 32881786
This page explains why vaginal leukoplakia pathology and colposcopy findings may not match for educational purposes only and does not constitute medical advice. Your gynecologist, pathologist, or gynecologic oncologist should interpret your report and recommend follow-up based on your findings.